Genmab Rings the Opening Bell

About This Event

Genmab (Nasdaq: GMAB), visits the Nasdaq MarketSite in Times Square. Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics.

In honor of the occasion, Jan van de Winkel, Ph.D., President and Chief Executive Officer, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore